Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo

NCT01243450 is registered in ClinicalTrials.gov with Spear Pharmaceuticals as lead sponsor.

NCT NCT01243450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01243450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo
Lead sponsor
Spear Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
October 31, 2010
Enrollment
958 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne